Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MK2578 for Anemia in Hemodialysis Patients
NCT00924781Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Biologic
01
Overview
A Phase 2 trial of MK2578 in anemia of chronic kidney disease (CKD-A), sponsored by Merck & Co.. Started Jun 2009; status: terminated.
02
Drugs
MK2578
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00924781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924781.